BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 1091999)

  • 21. Susceptibility of Candida albicans biofilms grown in a constant depth film fermentor to chlorhexidine, fluconazole and miconazole: a longitudinal study.
    Lamfon H; Porter SR; McCullough M; Pratten J
    J Antimicrob Chemother; 2004 Feb; 53(2):383-5. PubMed ID: 14729749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1-[(3-Aryloxy-3-aryl)propyl]-1H-imidazoles, new imidazoles with potent activity against Candida albicans and dermatophytes. Synthesis, structure-activity relationship, and molecular modeling studies.
    La Regina G; D'Auria FD; Tafi A; Piscitelli F; Olla S; Caporuscio F; Nencioni L; Cirilli R; La Torre F; De Melo NR; Kelly SL; Lamb DC; Artico M; Botta M; Palamara AT; Silvestri R
    J Med Chem; 2008 Jul; 51(13):3841-55. PubMed ID: 18529046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro studies of a new imidazole antimycotic, bifonazole, in comparison with clotrimazole and miconazole.
    Yamaguchi H; Hiratani T; Plempel M
    Arzneimittelforschung; 1983; 33(4):546-51. PubMed ID: 6683531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of two imidazole antimycotics, clotrimazole and miconazole on amino acid transport in Candida albicans.
    Yamaguchi H; Iwata K
    Sabouraudia; 1979 Sep; 17(3):311-22. PubMed ID: 394368
    [No Abstract]   [Full Text] [Related]  

  • 25. Direct membrane-damaging effect of sertaconazole on Candida albicans as a mechanism of its fungicidal activity.
    Agut J; Palacín C; Salgado J; Casas E; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1992 May; 42(5A):721-4. PubMed ID: 1627191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anti-Candida activities of azole antifungals in the presence of lysozyme in vitro].
    Abe S; Tansho S; Perera PD; Hiratani T; Nishiyama Y; Uchida K; Yamaguchi H
    Nihon Ishinkin Gakkai Zasshi; 1998; 39(2):103-7. PubMed ID: 9580036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fungicidal activity of miconazole against Candida spp. biofilms.
    Vandenbosch D; Braeckmans K; Nelis HJ; Coenye T
    J Antimicrob Chemother; 2010 Apr; 65(4):694-700. PubMed ID: 20130024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Action of miconazole at high concentrations against Candida albicans.
    D'Auria FD; Villa A; Simonetti N
    J Chemother; 1989 Jul; 1(4 Suppl):240-2. PubMed ID: 16312385
    [No Abstract]   [Full Text] [Related]  

  • 29. Germ tube-forming cells of Candida albicans are more susceptible to clotrimazole-induced killing than yeast cells.
    Niimi M; Kamiyama A; Tokunaga M; Tokunaga J; Nakayama H
    Sabouraudia; 1985 Feb; 23(1):63-8. PubMed ID: 3887603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Further studies on factors controlling phenotypic susceptibility of Candida albicans to miconazole kill.
    Beggs WH
    Res Commun Chem Pathol Pharmacol; 1990 Jan; 67(1):159-62. PubMed ID: 2183320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antifungal activity of Morinda citrifolia fruit extract against Candida albicans.
    Jainkittivong A; Butsarakamruha T; Langlais RP
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Sep; 108(3):394-8. PubMed ID: 19716507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative ability of various prescription and over-the-counter topical antifungal drug products to inhibit the growth of C. albicans.
    Miner N; Armstrong M
    Adv Wound Care; 1994 Nov; 7(6):53, 55-6. PubMed ID: 7795865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of the effects of several antifungal imidazole derivatives and polyenes on Candida albicans: an ultrastructural study by scanning electron microscopy.
    Bastide M; Jouvert S; Bastide JM
    Can J Microbiol; 1982 Oct; 28(10):1119-26. PubMed ID: 6295583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of culture media on the antifungal activity of miconazole and amphotericin B methyl ester.
    Hoeprich PD; Huston AC
    J Infect Dis; 1976 Oct; 134(4):336-41. PubMed ID: 789787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The mode of action of imidazole antimycotics: implications for sensitivity testing (author's transl)].
    Haller I
    Mykosen; 1979 Dec; 22(12):423-30. PubMed ID: 396473
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition of sterol biosynthesis in Candida albicans by imidazole-containing antifungals.
    Marriott MS
    J Gen Microbiol; 1980 Mar; 117(1):253-5. PubMed ID: 6993625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of miconazole on the ultrastructure of Candida albicans.
    de Nollin S; Borgers M
    Proc R Soc Med; 1977; 70 Suppl 1(Suppl 1):9-12. PubMed ID: 233843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro studies with terconazole.
    Isaacson DM; Foleno B; Tolman EL; Rosenthale ME
    Gynakol Rundsch; 1985; 25 Suppl 1():12-25. PubMed ID: 3891537
    [No Abstract]   [Full Text] [Related]  

  • 39. Changes in the cellular composition of Candida albicans resistant to miconazole.
    Sharma S; Khuller GK
    Indian J Biochem Biophys; 1996 Oct; 33(5):420-4. PubMed ID: 9029825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparison of the in vitro antifungal activities of clotrimazole, miconazole, Econazole and exalamide against clinical isolates of dermatophytes (author's transl)].
    Kusunoki T; Harada S
    Nihon Hifuka Gakkai Zasshi; 1982 May; 92(6):671-5. PubMed ID: 6981011
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.